Between August 25 and October 13 Flatiron added a 17-biomarker model to its 345,000-patient NSCLC dataset, launched breast and NSCLC Panoramic data in the UK, Germany and Japan, passed one million breast cancer patients and took Telescope international. Each of those lives only as a press release on the resources hub. flatiron.com has nine life sciences pages organised by buyer team and not one page for a cancer type or a named dataset; the only dataset page, /panoramic-data-video, is a heading and a video with no description. A biopharma lead searching "real-world data HER2-low breast cancer" or "NSCLC biomarker real-world data" has nowhere on flatiron.com to land, and the new product marketer, hired to take new offerings to market, has no page to send them to.
First action
Draft the Breast Cancer Panoramic page from the October 1 press release numbers.
How to measure it
Life sciences leads from dataset pages
- Now
- –
- Target
- 40 a quarter
- By
- 2 quarters
Steps
List the datasets
Every Panoramic and core dataset with its latest public numbers and countries.
Associate, Product Marketing (Real-World Evidence) 2 days
Agree the template
Counts, subgroups, biomarkers, endpoints, countries, publications, Telescope questions, call to action.
Associate, Product Marketing (Real-World Evidence) 2 days
Write breast and NSCLC first
From the August, September and October releases.
Associate, Product Marketing (Real-World Evidence) 1 week
Scientific review
Research Oncology checks every number and claim.
Research Oncology 3 days
Build in HubSpot
Page template plus a hidden form field carrying the dataset name.
Web and marketing operations lead 1 week
Link the network
Press releases, publication disease filters, buyer-team pages and the homepage.
Web and marketing operations lead 2 days
Add the rest
Prostate and the six hematology datasets.
Associate, Product Marketing (Real-World Evidence) 3 weeks
Report
Leads and pipeline by dataset page each month.
Associate, Revenue Operations monthly
Why it works
Build one evergreen page per Panoramic dataset (breast, NSCLC, prostate, the six hematology datasets) with the numbers already published: patient counts by subgroup (HR+, HER2-low, biomarker-tested), years covered, countries available, biomarkers and endpoints, three recent publications from the matching disease filter, three example questions to ask in Telescope, and a call to action that tells the Life Sciences Partnerships team which dataset the lead came from. Link each from its press release, the disease filter on the publications hub and the five buyer-team pages, and update the page, not just the newsroom, at every launch.
Biopharma teams are organised by indication and search that way; a page per dataset turns each launch into a permanent search and AI-assistant answer, gives sellers one link per indication and shows which datasets bring in leads.
Ready to use
ChecklistDataset page launch list
[ ] Patient count and subgroup counts with an "as of" date [ ] Countries available (US, UK, Germany, Japan) [ ] Biomarkers and specimen-level fields [ ] Validated endpoints [ ] Three recent publications from the disease filter [ ] Three example Telescope questions [ ] Form with the dataset name passed to Salesforce [ ] Linked from the press release and buyer-team pages
Risks and how to handle them
Numbers go stale after each launch
Make the dataset page update part of every launch checklist.
Pages read as data sheets, not answers
Lead each page with the research questions the dataset answers.
Evidence
- Press releaseAugust 25, 2026: the NSCLC Panoramic dataset gains a biomarker data model "spanning 17+ markers across 345,000+ patients", with specimen-level detail (collection date, test type, lab name) for EGFR, BRAF, KRAS, ALK, ROS1, RET, MET, HER2, NTRK and PD-L1, plus emerging markers such as KEAP1 and STK11.Source
- Press releaseSeptember 29, 2026: Breast Cancer and NSCLC Panoramic datasets launch in the UK, Germany and Japan, following the first multinational Panoramic launch (prostate) in January 2026; Flatiron calls itself "the first and only company to deliver truly global real-world data in these key oncology indications"; the US breast and NSCLC Panoramic datasets "span nearly 1.5M patients".Source
- Press releaseOctober 1, 2026: the Breast Cancer Panoramic dataset passes one million patients, "the largest rigorously curated breast cancer real-world dataset of its kind": 81K+ tracked from early to metastatic settings, 840K+ HR-positive, 167K+ HER2-positive and 455K+ HER2-low.Source
- Press releaseOctober 13, 2026: Flatiron Telescope, the AI-powered oncology intelligence platform launched earlier in 2026, extends to UK, German and Japanese data across "more than six million patients"; the Chief Product Officer's goal is for Telescope "to be the single pane of glass for all patients across Flatiron's global network".Source
- Your websiteflatiron.com sitemap (42 URLs, read October 21, 2026): the life sciences section is nine pages organised by buyer team (clinical development, HEOR & RWE, market access, regulatory, commercial) plus data, insights and Telescope. There is no page for any cancer type or named dataset; the only dataset page, /panoramic-data-video, carries one heading ("Flatiron's largest available real-world oncology datasets"), a video and no meta description. Every life sciences call to action goes to one form, /contact/real-world-evidence-solutions.Source
- HiringAssociate, Product Marketing (Real-World Evidence), New York, posted September 22, 2026: "Drive growth and retention for our real-world evidence solutions"; "Execute marketing plans, positioning and go-to-market strategies for new offerings and product features"; "Conduct market and competitor research"; "Develop sales enablement and training resources that support clinically and scientifically complex sales conversations"; and own "core marketing systems to ensure materials are organized, up-to-date".Source
- Your websiteThe resources hub (resources.flatiron.com, a HubSpot blog) lists 1,047 URLs in its sitemap, 523 of them publication summaries, and filters publications by nine disease areas (hematologic malignancies, bladder, breast, colorectal, gastric, esophageal, lung, ovarian, prostate). There is no newsletter or subscribe option on the homepage, the resources hub or the publications page; only RSS feeds.Source